These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 17904791)

  • 1. Analysis of surrogate markers for target-specific therapy in breast carcinomas using archival materials.
    Sasano H; Suzuki T; Moriya T
    Biomed Pharmacother; 2007 Oct; 61(9):543-7. PubMed ID: 17904791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
    Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U
    Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
    Orlando L; Del Curto B; Gandini S; Ghisini R; Pietri E; Torrisi R; Balduzzi A; Cardillo A; Dellapasqua S; Veronesi P; Viale G; Goldhirsch A; Colleoni M
    Breast; 2008 Oct; 17(5):506-11. PubMed ID: 18456496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
    Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
    Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue detection of biomolecular predictors in breast cancer.
    Nassiri M; Nadji M
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1225-32. PubMed ID: 16925488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target molecules in breast cancer.
    Mengel M; Hebel K; Kreipe H; von Wasielewski R
    Breast J; 2005; 11(1):34-40. PubMed ID: 15647076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tissue microarrays in immunohistochemistry].
    Krivolapov IuA; Khramtsov AI
    Arkh Patol; 2005; 67(2):48-50. PubMed ID: 15938123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation.
    Van den Eynden GG; Colpaert CG; Couvelard A; Pezzella F; Dirix LY; Vermeulen PB; Van Marck EA; Hasebe T
    Histopathology; 2007 Oct; 51(4):440-51. PubMed ID: 17593207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico method for identification of promising anticancer drug targets.
    Koborova ON; Filimonov DA; Zakharov AV; Lagunin AA; Ivanov SM; Kel A; Poroikov VV
    SAR QSAR Environ Res; 2009 Oct; 20(7-8):755-66. PubMed ID: 20024808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of tumor markers for the control of chemotherapy.
    Finek J; Holubec L; Topolcan O; Salvet J; Pikner R; Holdenrieder S; Stieber P; Lamerz R; Holubec Sen L; Svobodova S; Visokai V; Helmichova E
    Anticancer Res; 2005; 25(3A):1655-8. PubMed ID: 16035152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of pathology: tumour banks, quality of tissue and more?].
    Höfler H
    Verh Dtsch Ges Pathol; 2006; 90():46-51. PubMed ID: 17867579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined mass spectrometry- and immunohistochemistry-based approach to determine protein expression in archival melanoma--proof of principle.
    Rezaul K; Murphy M; Lundgren DH; Wilson L; Han DK
    Pigment Cell Melanoma Res; 2010 Dec; 23(6):849-52. PubMed ID: 20849468
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.
    Taylor CR; Levenson RM
    Histopathology; 2006 Oct; 49(4):411-24. PubMed ID: 16978205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tissue fixation and processing on breast cancer size.
    Pritt B; Tessitore JJ; Weaver DL; Blaszyk H
    Hum Pathol; 2005 Jul; 36(7):756-60. PubMed ID: 16084944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-specimen histopathology: a method to produce whole-mount breast serial sections for 3-D digital histopathology imaging.
    Clarke GM; Eidt S; Sun L; Mawdsley G; Zubovits JT; Yaffe MJ
    Histopathology; 2007 Jan; 50(2):232-42. PubMed ID: 17222252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemistry: an indispensable technique in routine cytology.
    Skoog L; Tani E
    Cytopathology; 2011 Aug; 22(4):215-29. PubMed ID: 21771092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathology background of targeted therapy; quality control in pathology].
    Kulka J; Szirtes I; Szász AM; Kupcsulik P; Kenessey I; Lotz G; Tímár J
    Magy Onkol; 2010 Dec; 54(4):343-50. PubMed ID: 21163765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.